Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic Escherichia coli bladder epithelial cell invasion in vitro

Microbiology Spectrum(2024)10.1128/spectrum.02712-23Source: DataRank Database

VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic Escherichia coli bladder epithelial cell invasion in vitro is a research paper published in Microbiology Spectrum (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.12)OA: goldTopics (45)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Samuel S. Chang ORCID,Krutika A. Pandit,Prachi Khekare,W. Randolph Warner,Philippe E. Zimmern ORCID

Live enrichment

PubMed:38240572 OpenAlex:https://openalex.org/W4391025402

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Grant: 1R01DK131267-01

Defining the dynamics of urobiome structure and function in postmenopausal women and its role in recurrent UTI susceptibility

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2024

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.02712-23

publisherhttps://doi.org/10.1128/spectrum.02712-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.02712-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38240572

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10913388

Fields of Study

Urinary Tract Infections ManagementUrinary Bladder and Prostate ResearchBladder and Urothelial Cancer Treatments0301 basic medicine03 medical and health sciences

MeSH Terms

Anti-Bacterial AgentsUrinary BladderCetylpyridiniumEpithelial CellsEscherichia coli InfectionsFemaleGentamicinsHumansUrinary Tract InfectionsUropathogenic Escherichia coli

Keywords

GentamicinMicrobiologyEnterococcus faecalisAntibioticsProteus mirabilisCetylpyridinium chloridePseudomonas aeruginosaUrinary systemEscherichia coliMedicineBiologyInternal medicineBacteriaUTIUrinary BladderCPCCetylpyridiniumEpithelial Cellsbladder instillationQR1-502recurrent urinary tract infectionAnti-Bacterial AgentsUrinary Tract InfectionsHumansUropathogenic Escherichia coliFemaleGentamicinsurinary tract infectionEscherichia coli InfectionsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being